Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of inhaled AZD5423 vs budesonide in COPD patients on formoterol
2011-005389-39Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Mar 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AZD5423 in chronic obstructive pulmonary disease (COPD), sponsored by AstraZeneca. Started Mar 2012; status: completed.
02
Drugs
AZD5423
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2011-005389-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005389-39.